These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______________ to _____________
|
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report .......................... |
|
Title of each class
|
Trading Symbol |
Name of each exchange on which registered
|
|
|
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
Emerging growth company |
|
|
International Financial Reporting Standards as issued by the International Accounting Standards Board ☐
|
Other ☐
|
| Page | ||
|
1 | ||
| 4 | ||
| 4 | ||
| 4 | ||
| 4 | ||
|
A. |
Selected Financial Data |
4 | |
|
B. |
Capitalization and Indebtedness |
4 | |
|
C. |
Reasons for the Offer and Use of Proceeds |
4 | |
|
D. |
Risk Factors |
4 |
| 27 |
|
A. |
Business Overview |
27 | |
|
B. |
Government Regulations |
30 | |
|
C. |
Organizational Structure |
60 | |
|
D. |
Property, Plants and Equipment |
60 |
| 62 | ||
| 62 |
|
A. |
Research and Development, Patents and Licenses |
83 | |
|
B. |
Trend Information |
83 | |
|
C. |
Off-Balance Sheet Arrangements |
83 | |
|
D. |
Tabular Disclosure of Contractual Obligations |
84 |
| 85 |
|
A. |
Directors and Senior Management |
85 | |
|
B. |
Compensation of Directors and Executive Officers |
89 | |
|
C. |
Board Practices |
92 | |
|
D. |
Employees |
106 | |
| E. |
Share ownership |
107 | |
| F. |
Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation
|
109 |
| 109 |
|
A. |
Major Shareholders |
109 | |
|
B. |
Related Party Transactions |
112 | |
|
C. |
Interests of Experts and Counsel |
113 |
| 113 |
|
A. |
Consolidated Statements and Other Financial Information |
113 | |
|
B. |
Significant Changes |
114 |
| 114 |
|
A. |
Offer and Listing Details |
114 | |
| 114 | |||
|
|
A. |
Plan of Distribution |
114 |
|
B. |
Markets |
114 | |
|
C. |
Selling Shareholders |
114 | |
|
D. |
Dilution |
114 | |
|
E. |
Expense of the Issue |
115 | |
| 115 |
|
A. |
Share Capital |
115 | |
|
B. |
Memorandum and Articles of Association |
115 | |
|
C. |
Material Contracts |
116 | |
|
D. |
Exchange Controls |
117 | |
|
E. |
Taxation |
118 | |
|
F. |
Dividends and Paying Agents |
133 | |
|
G. |
Statement by Experts |
133 | |
|
H. |
Documents on Display |
134 | |
|
I. |
Subsidiary Information |
134 |
|
135 | ||
|
135 |
|
135 | ||
|
135 | ||
|
135 | ||
| 136 | ||
| 138 | ||
| 138 | ||
| 138 | ||
| 138 | ||
| 139 | ||
| 139 | ||
| 139 | ||
| 139 | ||
| 140 | ||
| 140 | ||
| Item 16J. | Insider Trading Policies | 141 |
|
141 | ||
|
142 | ||
|
142 | ||
|
142 | ||
|
142 |
|
A.
|
Reserved |
|
B.
|
Capitalization and Indebtedness
|
|
C.
|
Reasons for the Offer and Use
of Proceeds |
|
D.
|
Risk Factors |
| • |
The aerospace industry is subject to significant regulation and oversight, and TAT
and its subsidiaries may incur significant fines, penalties and costs if TAT and its subsidiaries do not comply with these regulations.
|
| • |
TAT competes with a number of established companies in all aspects of TAT’s business,
many of which have significantly greater resources or capabilities than TAT. |
| • |
TAT derives a material share of its revenues from few major customers. If TAT loses
any of these customers or they reduce the amount of business they do with TAT, TAT’s revenues may be seriously affected. |
| • |
A part of the revenues of TAT and its subsidiaries are from contracts with the U.S.
and Israeli governments and are subject to special risks. A loss of all, or a major portion, of these revenues from government contracts
could have a material adverse effect on TAT’s operations. |
| • |
If TAT and its subsidiaries do not receive the governmental approvals necessary for
the export of their products, TAT’s revenues may decrease. Similarly, if TAT’s suppliers and partners do not receive their
government approvals necessary to export their products or designs to TAT, TAT’s revenues may decrease. |
| • |
TAT depends on a limited number of suppliers of components for certain of its products
and if TAT or any of its subsidiaries are unable to obtain these components when needed, they would experience delays in manufacturing
their products and TAT’s financial results could be adversely affected. |
| • |
TAT may face increased labor and raw materials costs. TAT may not be able to recoup
future increases in the cost of wages and raw materials required for its operations through price increases for its products. |
| • |
TAT’s future success depends on its ability to develop new offerings and technologies.
|
| • |
TAT may face significant risks in the management of its inventory, while failure to
effectively manage its inventory levels may result in supply imbalances that could harm its business. |
| • |
TAT’s backlog of projects under contract is subject to unexpected adjustments,
delays in payments and cancellations. |
| • |
TAT faces special risks from international sales operations which may have a material
adverse effect on TAT’s business, operating results and financial condition. |
| • |
TAT may engage in future acquisitions that could dilute TAT’s shareholders’
equity and harm TAT’s business, results of operations and financial condition. |
| • |
Our strategic partnerships and relationships carry inherent business risks. |
| • |
Rapid technological changes may adversely affect the market acceptance of TAT’s
products. |
| • |
TAT has fixed-price contracts with some of its customers and TAT bears the risk of
costs in excess of its estimates. In addition, TAT may not be able to pass on increased costs to its customers. |
| • |
TAT depends on its key executives; it may not be able to hire and retain additional
key employees or successfully integrate new members of its team; the loss of key employees could have a material adverse effect on TAT’s
business. |
| • |
TAT depends on its manufacturing and MRO facilities and any material damage to these
facilities may adversely impact TAT’s operations. |
| • |
TAT uses equipment that is not easily repaired or replaced, and therefore material
equipment failures could cause TAT or its subsidiaries to be unable to meet quality or delivery expectations of its customers. |
| • |
TAT may fail to maintain effective internal controls in accordance with Section 404
of the Sarbanes-Oxley Act of 2002. |
| • |
TAT has potential exposure to liabilities arising under environmental laws and regulations.
|
| • |
TAT is exposed to potential liabilities arising from product liability and warranty
claims. |
| • |
Significant disruptions of TAT’s information technology systems or breaches of
its data security could adversely affect TAT’s business. |
| • |
TAT’s activity in Israel may be adversely affected by a change in the exchange
rate of the NIS against the U.S Dollars. As exchange rates between the NIS and the dollar fluctuate continuously, exchange rate
fluctuations, particularly larger periodic devaluations, may have an impact on TAT’s profitability and period to period comparisons
of TAT’s results. |
| • |
TAT’s share price has been volatile in the past and may decline in the future.
|
| • |
Substantial future sales of TAT’s ordinary shares by TAT’s principal shareholders
may depress TAT’s share price. |
| • |
Because TAT has significant operations in Israel, TAT may be subject to political,
economic and other conditions affecting Israel that could increase TAT’s operating expenses and disrupt TAT’s business.
|
| • |
The war in Israel and other conditions in Israel could materially affect TAT’s
business. |
| • |
TAT’s results of operations may be negatively affected by the obligation of its
personnel to perform military service. |
| • |
Your rights and responsibilities as a shareholder are governed by the Israeli law and
may differ in some respects from the rights and responsibilities of shareholders under U.S. law. |
| • |
Israeli law may delay, prevent or make difficult an acquisition of TAT, which could
prevent a change of control and, therefore, depresses the price of TAT’s shares. |
| • |
Investors and TAT’s shareholders generally may have difficulties enforcing a
U.S. judgment against TAT, TAT’s executive officers and directors in Israel or the United States, or asserting U.S. securities laws
claims in Israel. |
| • |
As a foreign private issuer whose shares are listed on the NASDAQ, TAT may follow certain
home country corporate governance practices instead of certain NASDAQ requirements. |
| (i) |
Manufacturers based in the United States, such as the Hughes-Treitler division of Ametek Inc., Boyd Corporation, Collins Aerospace,
Honeywell International, and Triumph Thermal Systems; |
| (ii) |
Manufacturers based in Europe such as HS Marston Aerospace Ltd., a subsidiary of Collins Aerospace, Secan and Liebherr-Aerospace
Toulouse S.A.; and |
| (iii) |
Manufacturers based in Asia such as Sumitomo Precision Products from Japan. |
|
• |
The ability to adapt faster
to changes in customer requirements and industry conditions or trends; |
|
• |
Greater access to capital;
|
|
• |
Stronger relationships with
customers and suppliers; |
|
• |
Greater name recognition;
|
|
• |
Access to superior technology
and greater marketing resources; |
|
• |
The ability to offer complete
systems in addition to components; and |
|
• |
The ability to bundle heat
transfer components and solutions and other aircraft components. |
| • |
Suspend TAT or any of its subsidiaries from receiving new contracts pending resolution of alleged violations of procurement laws
or regulations; |
|
• |
Terminate existing contracts,
with or without cause, at any time; |
|
• |
Condition the receipt of new
contracts on conditions which are beyond the control of TAT; |
|
• |
Reduce the value of existing
contracts; |
| • |
Audit the contract-related costs and fees of TAT and its subsidiaries, including allocated indirect costs; and |
|
• |
Control or prohibit the export
of products of TAT and its subsidiaries. |
|
• |
Governmental embargoes or foreign
trade restrictions; |
|
• |
Changes in U.S. and foreign
governmental regulations; |
|
• |
Changes in foreign exchange
rates; |
|
• |
Tariffs; |
|
• |
Other trade barriers;
|
|
• |
Political, economic and social
instability; and |
|
• |
Difficulties collecting accounts
receivable. |
|
• |
Issuance of equity securities
that would dilute TAT’s shareholders’ percentages of ownership; |
|
• |
Large one-time write-offs;
|
|
• |
The incurrence of debt and
contingent liabilities; |
| • |
Difficulties in the assimilation and integration of operations, personnel, technologies, products and information systems of the
acquired companies; |
|
• |
Diversion of management’s
attention from other business activities and concerns; |
|
• |
Contractual disputes;
|
| • |
Risks of entering geographic and business markets in which TAT has no or only limited prior experience; and |
|
• |
Potential loss of key employees
of acquired organizations. |
|
• |
Quarterly variations in TAT’s
operating results; |
|
• |
Operating results that vary
from the expectations of securities analysts and investors; |
| • |
Changes in expectations as to TAT’s future financial performance, including financial estimates by securities analysts and
investors; |
|
• |
Announcements of technological
innovations or new products by TAT or TAT’s competitors; |
| • |
Announcements by TAT or TAT’s competitors of significant contracts, acquisitions, strategic partnerships, joint ventures or
capital commitments; |
|
• |
Announcements by third parties
of significant claims or proceedings against us; |
|
• |
Additions or departures of
key personnel; |
|
• |
Future sales of TAT’s
ordinary shares by the Company (such as the issuance and sale in December 2023) or by our controlling shareholders or others;
|
|
• |
The effects of the war and
hostilities between Israel and Hamas, Hezbollah and Iran; |
|
• |
De-listing of TAT’s shares
from NASDAQ and/or from the TASE; |
|
• |
Stock market price and volume
fluctuation; |
|
• |
Legal proceedings against TAT
or its controlling shareholders; and |
|
• |
Regulatory actions by securities
authorities which impacts TAT’s interaction with securities analysts and institutional investors. |
|
A. |
Business Overview |
| |
Business Overview |
| • |
Enhancing OEM capabilities - capitalizing on our technical expertise,
experience and reputation in the market of heat transfer solutions to expand the scope of our OEM offerings to new aircrafts or to new
platforms in the existing aircrafts. |
| • |
Expand the scope of MRO services - leveraging
our technical expertise, engineering resources and facilities to broaden MRO services to additional types of aircraft and additional aircraft
systems, subsystems and components while developing the required technical expertise to provide these additional MRO services. |
| • |
Increasing market share - continuing aggressive marketing efforts to win
new customers as well as to expand activities with existing customers, partly by focusing on cross selling opportunities between our different
businesses. As part of our efforts, we also intend to expand our marketing presence in existing territories, like the United States and
Western Europe as well as new territories, where TAT currently has a smaller presence and fewer customers, such as Eastern Europe, Latin
America and Asia. |
| • |
Effective synergy among group members - enhancing the synergies between
our various businesses. For example, by supplying TAT Israel with heat transfer components manufactured in Limco for the sale of heat
exchangers. |
| • |
Organic growth and M&A - in addition to growing our existing businesses
organically as detailed above, we intend to evaluate complementary acquisition opportunities. |
|
Aircraft manufacturers |
Boeing, Textron, Pilatus, Embraer, Lockheed Martin, Honda Aircraft, Cirrus, Gulfstream,
Raytheon-Collins |
|
System manufacturers/integrators and defense contractors
|
Liebherr, Rafael, Elbit, IAI, Parker, Eaton Aerospace, Safran. |
|
U.S. Domestic and international airlines and air cargo carriers |
Air France-KLM, Lufthansa, FedEx, UPS, American Airlines, Delta Airlines, United Airlines,
Air Canada Jazz, Republic Airways, DHL, Austrian Airlines, TAM, Thai, Korean Air, Air India, Swiftair, Allegiant Air, Empire Airlines,
Mountain Air Cargo, Alliance Airlines, |
|
Maintenance service centers |
Fokker, Honeywell International, Kellstrom Commercial, Aero Kool, Lufthansa Technik, RTX through Collins,
SR Technics, Embraer, Turkish Technic, Delta Tech Ops, ST Aerospace Engineering, , Gulfstream, IAI, Haeco Americas , Air New-Zeeland,
AAR. |
|
Governments and military air forces |
U.S. Army, U.S. Air Force and U.S. Navy; Israeli Ministry of Defense, Israeli Air
Force; Belgium Air Force, Polish Air Force, Portuguese Air Force, Japan Air Force. |
| • |
Complete system manufacturers that either independently or through subcontractors, design, develop and manufacture complete systems
(such as a manufacturer of aircraft hydraulic systems) directly for the platform manufacturer (i.e., for business jets). These companies
will typically compete on bids for complete systems and/or projects where the components/products TAT develops are part of the complete
system. In such cases, it is very likely that these companies will subcontract to companies such as TAT the design and manufacturing of
one or a few components in the system. Although some of these companies have the capabilities to design and manufacture each standalone
component in a complete system (i.e., a heat exchanger integrated in hydraulic systems) they usually do not compete with TAT in projects
where there is a specific requirement for a stand-alone component. |
| • |
Component manufacturers, such as TAT, for which the design and manufacture of components (such as heat exchangers or other types
of heat transfer solutions) is the main business (and which are normally situated in the “value chain” one tier below the
system manufacturers, such as a manufacturer of an aircraft’s hydraulic system and two tiers below the platform manufacturer, such
as a manufacturer of a new aircraft). These companies typically compete in projects where there is a specific requirement for a standalone
aviation component (such as a heat exchanger or other types of heat transfer solutions) and in tenders by manufacturers of complete systems
or products for sub-contractors. Although some of the component manufacturers have the capabilities to design, develop and manufacture
a complete system (i.e., environmental control system for a business jet) for a certain platform, these companies usually do not compete
on projects for complete systems in which their manufactured component constitutes a small part of the complete system, mainly due to
the high barriers to entry and to the difficulty to move up the “value chain” from a component supplier to a whole system
manufacturer. |
|
• |
The ability to adapt faster to changes in customer requirements and industry conditions
or trends; |
|
• |
Greater access to capital; |
|
• |
Stronger relationships with customers and suppliers; |
|
• |
Greater name recognition; |
|
• |
Access to superior technology and greater marketing resources; |
|
• |
Ability to offer complete systems in addition to components; and |
|
• |
The ability to bundle heat transfer solutions and other aircraft components. |
| • |
Service divisions of OEMs – generally, each OEM of products in the heat transfer solutions segment has the necessary capabilities
to provide MRO services for products it designs and manufactures throughout its lifetime, commencing with the initial warranty period
and through the after-market period. Service divisions of OEMs may also acquire capabilities to service products of other OEMs to further
expand their MRO services. |
| • |
Service centers – which often provide MRO services for a broad range of components and systems. These service centers can be
either the in-house maintenance services of commercial airlines or other independent service providers, such as TAT Israel and TAT Limco.
|
|
• |
Ability to bundle heat transfer and other aircraft components; |
|
• |
Access to greater marketing resources; |
|
• |
Access to superior technology; and |
|
• |
Greater resources which allow for better turnaround time. |
|
• |
Better name recognition; |
|
• |
Ability to bundle aviation and other aircraft components; |
|
• |
Stronger relationships with customers and suppliers; |
|
• |
Lower cost structure; |
|
• |
Regional support near customers’ location; |
|
• |
Access to greater marketing resources; |
|
• |
Access to superior technology |
|
• |
Greater access to capital; and |
|
• |
Greater resources which allow for better turnaround time. |
|
• |
The ability to adapt faster to changes in customer requirements and industry conditions
or trends; |
|
• |
Better name recognition; |
|
• |
Ability to bundle jet engine and other aircraft components; |
|
• |
Stronger relationships with customers, OEMs and suppliers; |
|
• |
Lower cost structure; |
|
• |
Regional support near customers’ location; |
|
• |
Access to greater marketing resources; |
|
• |
Access to superior technology; |
|
• |
Greater access to capital; and |
|
• |
Greater resources which allow for better turnaround time |
| • |
Engaging in Pro-active Account Management efforts to preserve its customer base in existing projects, while working to broaden and
increase its involvement with such clients. |
| • |
Conducting marketing activities aimed at penetrating new geographical markets and winning new customers, while taking advantage of
the unique knowledge and expertise that TAT and its subsidiaries have gained in various areas. |
| • |
Entering into additional related operating segments that will enable TAT and its subsidiaries to fulfill their growth potential.
|
| • |
Providing customers with the best value, including competitive prices, by tailoring comprehensive service packages that combine the
design and planning of an OEM component, the manufacture of such component, and the provision of maintenance services. |
| • |
Extending MRO capabilities in order to establish a ‘one-stop-shop’ center for comprehensive MRO services for the types
of aircraft Limco and/or Piedmont and/or Turbochrome target. |
| • |
Enhancing our engineering capabilities in order to support customer needs related to new projects and in order to certify MRO services
that differ from processes previously approved by the FAA, EASA or other regulatory authorities. This allows shortening the long and complex
approval process, streamlining the design and certification process and reducing costs. |
| • |
Leveraging operational efficiencies to achieve shorter delivery times and reduce costs. |
| • |
Investing in new technologies and manufacturing techniques in the heat transfer solutions product line. |
| • |
Investing in innovations and improvements aimed at enhancing the quality and performance of our existing solutions and services as
well as the development of new products in an effort to strengthen our market position and enter into more advanced platforms. |
| • |
Performance Optimization: Achieving superior heat transfer efficiency while meeting stringent cooling requirements for modern aviation
systems. |
| • |
Physical Characteristics Enhancement: Reducing system size and weight to align with eVTOL and electric aircraft operational constraints.
|
| • |
Reliability and Durability: Extending product lifespan by leveraging advanced materials, manufacturing techniques, and rigorous testing
protocols. |
| • |
High-fidelity heat exchanger testing platforms capable of simulating real-world thermal conditions, including dynamic temperature,
pressure, and multi-phase flow. |
| • |
Integrated predictive modeling and simulation tools to accelerate the design and validation process. |
| • |
Real-time data acquisition and performance measurement systems for precise evaluation of thermal efficiency and reliability.
|
| • |
Scalable platforms for testing traditional and advanced technologies, including next-generation 3D-printed heat exchangers and custom
thermal solutions. |
| • |
Identifying emerging market needs and technological challenges. |
| • |
Co-developing tailored solutions that meet specific operational and environmental constraints. |
| • |
Accelerating product development timelines through iterative testing, feedback, and refinement. |
| • |
Deliver cutting-edge solutions that set new industry benchmarks. |
| • |
Adapt and respond to market potential with agility and precision. |
| • |
Exceed customer expectations by providing future-ready thermal management systems. |
|
B. |
Government Regulations |
|
C. |
Organizational Proceedings |
|
D. |
Property, Plants and Equipment |
| (i) |
OEM of heat transfer solutions and aviation components, such as heat exchangers, pre-coolers and oil/fuel hydraulic coolers (through
TAT Israel); |
| (ii) |
MRO services for heat transfer components and OEM of heat transfer solutions (through our Limco subsidiary); |
| (iii) |
MRO services for aviation components (through our Piedmont subsidiary); and |
| (iv) |
Overhaul and coating of jet engine components (through our Turbochrome subsidiary). |
|
|
Year Ended December 31, |
|||||||||||||||||||||||
|
|
2024 |
2023 |
2022 |
|||||||||||||||||||||
|
|
Revenues in Thousands |
% of Total Revenues |
Revenues in Thousands |
% of Total Revenues |
Revenues in Thousands |
% of Total Revenues |
||||||||||||||||||
|
Revenues |
||||||||||||||||||||||||
|
OEM of heat transfer solutions and aviation accessories
|
36,466 |
24 |
% |
27,555 |
24.2 |
% |
21,844 |
25.8 |
% | |||||||||||||||
|
MRO services for heat transfer components and OEM of heat transfer
solutions |
43,863 |
28.8 |
% |
32,995 |
29 |
% |
24,796 |
29.3 |
% | |||||||||||||||
|
MRO services for aviation components |
67,475 |
44.3 |
% |
50,760 |
44.5 |
% |
35,879 |
42.4 |
% | |||||||||||||||
|
Overhaul and coating of jet engine components |
7,392 |
4.9 |
% |
6,854 |
6 |
% |
5,770 |
6.8 |
% | |||||||||||||||
|
Eliminations |
(3,080 |
) |
(2 |
)% |
(4,370 |
) |
(3.7 |
)% |
(3,733 |
) |
(4.3 |
)% | ||||||||||||
|
Total Revenues |
$ |
152,116 |
100 |
% |
$ |
113,794 |
100 |
% |
$ |
84,556 |
100 |
% | ||||||||||||
|
|
Years Ended December 31, |
|||||||||||||||||||||||
|
|
2024 |
2023 |
2022 |
|||||||||||||||||||||
|
|
Revenues in Thousands |
% of Total Revenues |
Revenues in Thousands |
% of Total Revenues |
Revenues in Thousands |
% of Total Revenues |
||||||||||||||||||
|
United States |
104,326 |
68.6 |
% |
$ |
81,999 |
72 |
% |
$ |
56,570 |
66.9 |
% | |||||||||||||
|
Israel |
7,868 |
5.2 |
% |
7,697 |
7 |
% |
7,162 |
8.5 |
% | |||||||||||||||
|
Other |
39,922 |
26.2 |
% |
24,098 |
21 |
% |
20,824 |
24.6 |
% | |||||||||||||||
|
Total |
$ |
152,116 |
100 |
% |
$ |
113,794 |
100 |
% |
$ |
84,556 |
100.0 |
% | ||||||||||||
| • |
Inventory valuation; |
| • |
Income taxes; and |
| • |
Allowance for current expected credit losses (CECL). |
|
|
Year Ended December 31 |
|||||||||||
|
|
2024 |
2023 |
2022 |
|||||||||
|
|
(in thousands) |
|||||||||||
|
Revenues |
||||||||||||
|
OEM of heat transfer solutions and aviation accessories |
$ |
36,466 |
$ |
27,555 |
21,844 |
|||||||
|
MRO services for heat transfer components and OEM of heat transfer solutions
|
43,863 |
32,995 |
24,796 |
|||||||||
|
MRO services for aviation components |
67,475 |
50,760 |
35,879 |
|||||||||
|
Overhaul and coating of jet engine components |
7,392 |
6,854 |
5,770 |
|||||||||
|
Eliminations |
(3,080 |
) |
(4,370 |
) |
(3,733 |
) | ||||||
|
Total revenues |
152,116 |
113,794 |
84,556 |
|||||||||
|
Cost of revenues |
||||||||||||
|
OEM of heat transfer solutions and aviation accessories |
24,965 |
20,193 |
18,778 |
|||||||||
|
MRO services for heat transfer components and OEM of heat transfer solutions
|
35,978 |
30,176 |
20,750 |
|||||||||
|
MRO services for aviation components |
56,798 |
41,788 |
28,890 |
|||||||||
|
Overhaul and coating of jet engine components |
4,823 |
4,110 |
3,495 |
|||||||||
|
Eliminations |
(3,462 |
) |
(4,941 |
) |
(3,285 |
) | ||||||
|
Total cost of revenues |
119,102 |
91,326 |
68,628 |
|||||||||
|
Gross profit |
33,014 |
22,468 |
15,928 |
|||||||||
|
Research and development costs, net |
1,248 |
715 |
479 |
|||||||||
|
Selling and marketing |
7,746 |
5,523 |
5,629 |
|||||||||
|
General and administrative |
11,901 |
10,558 |
9,970 |
|||||||||
|
Other expenses (income) |
(383 |
) |
(433 |
) |
(90 |
) | ||||||
|
Restructuring expenses, net |
- |
- |
1,715 |
|||||||||
|
Operating income (loss) |
12,502 |
6,075 |
(1,775 |
) | ||||||||
|
Financial income (expense), net |
(1,949 |
) |
(1,330 |
) |
127 |
|||||||
|
Income (loss) before taxes on income (tax benefit) |
10,553 |
4,745 |
(1,648 |
) | ||||||||
|
Taxes on income (tax benefit) |
195 |
576 |
98 |
|||||||||
|
income (loss) before equity investment |
10,358 |
4,169 |
(1,746 |
) | ||||||||
|
Share in results of affiliated company and impairment of share in
affiliated companies |
809 |
503 |
184 |
|||||||||
|
Net income (loss) |
$ |
11,167 |
$ |
4,672 |
$ |
(1,562 |
) | |||||
|
|
Year Ended December 31, |
|||||||||||
|
|
2024 |
2023 |
2022 |
|||||||||
|
Revenues |
||||||||||||
|
OEM of heat transfer solutions and aviation components |
24.0 |
% |
24.2 |
% |
25.8 |
% | ||||||
|
MRO services for heat transfer components and OEM of heat transfer solutions
|
28.8 |
29 |
29.3 |
|||||||||
|
MRO services for aviation components |
44.3 |
44.5 |
42.4 |
|||||||||
|
Overhaul and coating of jet engine components |
4.9 |
6 |
6.8 |
|||||||||
|
Eliminations |
(2.0 |
)
|
(3.7 |
) |
(4.4 |
) | ||||||
|
Total revenues |
100 |
100 |
100 |
|||||||||
|
Cost of revenues |
||||||||||||
|
OEM of heat transfer solutions and aviation components |
16.4
|
17.4
|
22.2
|
|||||||||
|
MRO services for heat transfer components and OEM of heat transfer solutions
|
23.7 |
26.5 |
24.5 |
|||||||||
|
MRO services for aviation components |
37.3
|
36.7
|
34.2
|
|||||||||
|
Overhaul and coating of jet engine components |
3.2
|
3.6
|
4.1
|
|||||||||
|
Eliminations |
(2.3
|
)
|
(4 |
) |
(3.9 |
) | ||||||
|
Cost of revenues |
78.3
|
80.2
|
81.2
|
|||||||||
|
Gross profit |
21.7
|
19.7
|
18.8
|
|||||||||
|
Research and development costs, net |
0.8
|
0.6
|
0.6
|
|||||||||
|
Selling and marketing |
5.1
|
4.8
|
6.7
|
|||||||||
|
General and administrative |
7.8
|
9.3
|
11.8
|
|||||||||
|
Other expenses (income) |
(0.3 |
) |
(0.4 |
) |
(0.1 |
) | ||||||
|
Restructuring expenses, net |
0
|
0
|
2
|
|||||||||
|
13.4
|
14.3
|
21
|
||||||||||
|
Operating income (loss) |
8.2
|
5.3
|
(2.1 |
) | ||||||||
|
Financial income (expense), net |
(1.3 |
) |
(1.2 |
) |
0.2
|
|||||||
|
Income (loss) before taxes on income (tax benefit) |
6.9
|
4.2
|
(1.9 |
) | ||||||||
|
Taxes on income (tax benefit) |
0.1
|
0.5
|
0.1
|
|||||||||
|
income (loss) before equity investment |
6.8
|
3.7
|
(2.1 |
) | ||||||||
|
Share in results of affiliated company and impairment of share in
affiliated companies |
0.5
|
0.4
|
0.2
|
|||||||||
|
Net income (loss) |
7.3 |
% |
4.1 |
% |
(1.8 |
)% | ||||||
|
Total
long term loans and credit
line
balance amount as of the
year ended December 31
|
||||||||||||||||||||
|
2024 |
2023 |
2022 |
Rate |
Duration |
||||||||||||||||
|
Israel |
||||||||||||||||||||
|
Gov guaranteed loans (see a) |
3,990 |
4,707 |
5,517 |
(*) 7.75 |
% |
5-10 |
||||||||||||||
|
Commercial loans (see b) |
2,171 |
2,601 |
3,116 |
(*) 7.15 |
% |
7 |
||||||||||||||
|
USA |
||||||||||||||||||||
|
Commercial loans (see c) |
6,285 |
7,076 |
7,651 |
3.75% - 4.2 |
% |
5-10 |
||||||||||||||
|
Line of Credit (see d) |
4,350 |
12,137 |
11,101 |
(*) 7.25%-8.6 |
% |
Revolving |
||||||||||||||
|
Machinery finance loans (see e) |
575 |
712 |
- |
6.65 |
% |
5 |
||||||||||||||
|
17,371 |
27,224 |
27,385 |
||||||||||||||||||
| a. |
TAT received several loans from Israeli banks (with a guaranty from the Israeli government) during 2020 and 2021 in an aggregate
amount of $6.3 million. The loans bear annual interest (Prime Rate +1.5%) which are paid in equal monthly installments as of April 2021
through February 2031. The aforementioned loans were received in NIS. |
| b. |
In March 2022, TAT received a loan from a commercial bank in the amount of $3.7 million. The loan bears annual interest (Prime Rate
+0.9%) and paid in equal monthly installment as of April 2022 through March 2029. |
| c. |
In May 2022, a TAT US subsidiary received a loan from a commercial bank in the US in the amount of $3 million. The loan is secured
with a first-degree lien on the US subsidiary’s equipment. The loan bears an annual interest which is paid in equal monthly installments
until 2029. In August 2022, another TAT US subsidiary received a long-term loan of $5 million from a commercial bank in the US. The loan
bears an annual interest which is paid in equal monthly installments until August 2032. The loan is secured with a first-degree lien on
the US subsidiary’s equipment. |
| d. |
In February 2022, a TAT US subsidiary received a credit line from a US commercial bank in the amount of $7 million with a maturity
date of February 2024 carrying an interest of WSJP+0.1%. In February 2024, the US subsidiary signed a new loan contract extending the
existing line of credit by 2 years and securing an additional credit in the amount of $7 million (total line of credit of $14 million).
As of December 31, 2024, $2.85 million of this credit line was utilized. In March 2022, another TAT US subsidiary received
a credit line of $5 million from a commercial bank. This credit line bears an initial annual fixed interest of 2.9%. In April 2024, the
US subsidiary signed a contract extending the existing line of credit by 2 years. This credit line bears annual fixed interest of 7.25%.
As of December 31, 2024, $1.5 million of this credit line was utilized. |
| e. |
In 2023 a TAT US subsidiary received loans from Machinery Finance in the total amount of $0.7 million. The loans bear annual interest
which are paid in equal monthly installments until 2028. |
| f. |
In June 2023, TAT secured another short-term line of credit from an Israeli bank for $4.5 million. The Company’s building and
land in Kiryat Gat serve as collateral for this loan. As of December 31, 2024, the Company has not utilized this credit line |
|
|
Year Ended December 31, |
|||||||||||
|
|
(in thousands) |
|||||||||||
|
|
2024 |
2023 |
2022 |
|||||||||
|
Net cash provided by (used in) operating activities |
$ |
(5,818 |
) |
$ |
2,255 |
$ |
(4,867 |
) | ||||
|
Net cash used in investing activities |
(3,851 |
) |
(3,579 |
) |
(16,120 |
) | ||||||
|
Net cash provided by financing activities |
161 |
10,240 |
15,798 |
|||||||||
|
Net increase (decrease) in cash and cash equivalents |
(9,508 |
) |
8,916 |
(5,189 |
) | |||||||
|
Cash and cash equivalents at beginning of the year |
16,942 |
8,026 |
13,215 |
|||||||||
|
Cash and cash equivalents at end of the year |
$ |
7,434 |
$ |
16,942 |
$ |
8,026 |
||||||
|
A. |
Research and Development, Patents and Licenses |
|
B. |
Trend Information |
|
C. |
Off-Balance Sheet Arrangements |
|
D. |
Tabular Disclosure of Contractual Obligations |
|
Contractual Obligations |
Payments due by Period
(Amounts in Thousands of US$) |
|||||||||||||||||||
|
Total |
Less than 1 year |
1-3 Years |
3-5 Years |
More than 5 years |
||||||||||||||||
|
Operating lease obligations |
2,285 |
939 |
916 |
276 |
154 |
|||||||||||||||
|
Purchase commitments |
38,219 |
33,578 |
4,241 |
400 |
- |
|||||||||||||||
|
Total |
$ |
40,504 |
34,517 |
5,157 |
676 |
154 |
||||||||||||||
|
A. |
Directors and Senior Management |
|
Name |
Age |
Position |
| ||
|
Amos Malka |
73 |
Chairman of the Board of Directors |
| ||
|
Igal Zamir |
|
60 |
|
Chief Executive Officer and President |
|
|
Ehud Ben – Yair |
62 |
Chief Financial Officer |
|||
|
Liron Topaz |
44 |
General Manager of TAT Israel |
|||
|
Marty Carvellione |
47 |
General Manager of Piedmont |
|||
|
Jason Lewandowski |
51 |
Chief Operational Officer |
|||
|
Paul Maness |
41 |
General Manager of Limco |
|||
|
Lars Hesbjerg
|
59
|
Vice President Sales |
|||
|
Gillon Beck |
64 |
Director |
|||
|
Moti Glick (1)(2)(3)(4) |
|
73 |
|
External Director |
|
|
Ronnie Meninger (1)(3)(4) |
|
69 |
|
Independent Director |
|
|
Aviram Halevi (1)(2)(3)(4) |
68 |
External Director |
|
B. |
Compensation of Directors and Executive Officers |
|
|
Salaries, fees, Commissions and bonuses (Amounts in Thousands US$) |
Other benefits (Amounts in Thousands US$) |
||||||
|
All directors and executive officers as a group (12 executives) |
$ |
3,467 |
$ |
108 |
||||
|
Information Regarding Covered Executives (1)
(Amounts in Thousands US$) |
||||||||||||||||||||
|
Name and Principal Position(2)
|
Base Salary |
Benefits and
Perquisites(3) |
Variable Compensation(4)
|
Equity-Based
Compensation(5) |
Total |
|||||||||||||||
|
Igal Zamir, CEO and President |
339 |
130 |
346 |
20 |
835 |
|||||||||||||||
|
Ehud Ben- Yair, CFO |
324 |
57 |
225 |
96 |
702 |
|||||||||||||||
|
Jason Lewandowski, COO |
267 |
22 |
152 |
31 |
472 |
|||||||||||||||
|
Liron Topaz, GM TAT Israel |
156 |
71 |
68 |
37 |
328 |
|||||||||||||||
|
Lars Hebjerg, VP Sales |
221 |
23 |
62 |
37 |
323 |
|||||||||||||||
|
(1) |
All amounts reported in the table are in terms of cost to TAT,
as recorded in our financial statements. | |
|
(2) |
Cash compensation amounts denominated in currencies other than
the U.S. dollar were converted into U.S. dollars at the average conversion rate for the year ended December 31, 2024. | |
|
(3) |
Amounts reported in this column include benefits and perquisites,
including those mandated by applicable law. Such benefits and perquisites may include, to the extent applicable to each executive, payments,
contributions and/or allocations for savings funds, pension, severance, vacation, car or car allowance, medical insurance and benefits,
risk insurance (e.g., life, disability, accident), convalescence pay, payments for social security, tax gross-up payments and other benefits
and perquisites consistent with our guidelines. | |
|
(4) |
Amounts reported in this column refer to variable compensation mainly bonus payments
according to the company's incentive plan as recorded in our financial statements for the year ended December 31, 2024 and were paid during
2024 in respect of performance related to fiscal year 2023 and 2022 results and special bonus for the private placements was paid in 2024.
| |
|
(5) |
Amounts reported in this column represent the expense recorded
in our financial statements for the year ended December 31, 2024 in connection with equity-based compensation granted to the Covered Executive.
|
|
C. |
Board Practices |
| • |
The majority includes at least a majority of the shares voted by shareholders other than controlling shareholders or shareholders
who have a personal interest in the election of the external directors (excluding a personal interest that is not related to a relationship
with the controlling shareholders); or |
| • |
The total number of shares held by non-controlling shareholders and disinterested shareholders that voted against the election of
the external director does not exceed 2% of the aggregate voting rights of the company. |
| • |
The majority includes at least a majority of the shares voted by shareholders who have no personal interest in the transaction; or
|
| • |
The total number of shares held by disinterested shareholders that voted against the approval of the transaction does not exceed
2% of the aggregate voting rights of our company. |
| • |
The majority includes at least a majority of the shares voted by shareholders other than our controlling shareholders or shareholders
who have a personal interest in the adoption of the compensation policies; or |
| • |
The total number of shares held by non-controlling shareholders and disinterested shareholders that voted against the adoption of
the compensation policies does not exceed 2% of the aggregate voting rights of our company. |
|
Active Chairman |
CEO |
Other Executives | |
|
Company Target |
100% |
75% - 100% |
50%-100% |
|
Personal KPIs |
NONE |
NONE |
0%-30% |
|
Personal Evaluation |
NONE |
0%-25% |
0%-30% |
| • |
Breach of his or her duty of care to the company or to another person; |
| • |
Breach of his or her duty of loyalty to the company, provided that the office holder acted in good faith and had reasonable cause
to assume that his act would not prejudice the company’s interests; |
| • |
Monetary liability imposed upon the office holder in favor of another person; |
| • |
A monetary obligation imposed on the office holder in favor of another person who was injured by a violation, as this term is defined
in section 52(54)(a)(1)(a) of the Israeli Securities Law, 1968 (“Israeli Securities Law”); and |
| • |
Expenses expended by the office holder, including reasonable litigation expenses, and including attorney's fees, in respect of any
proceeding under chapters 8-C, 8-D or 9-A of the Israeli Securities Law or in respect to any monetary sanction. |
| • |
Monetary liability imposed on the office holder in favor of another person by any judgment, including a settlement or an arbitrator’s
award approved by a court; |
| • |
Reasonable litigation expenses, including attorney’s fees, actually incurred by the office holder as a result of an investigation
or proceeding instituted against him or her by a competent authority, provided that such investigation or proceeding concluded without
the filing of an indictment against the office holder or the imposition of any monetary liability in lieu of criminal proceedings, or
concluded without the filing of an indictment against the office holder and a monetary liability was imposed on the officer holder in
lieu of criminal proceedings with respect to a criminal offense that does not require proof of criminal intent; |
| • |
A monetary obligation imposed on the office holder in favor of another person who was injured by a violation, as this term is defined
in section 52(54)(a)(1)(a) of the Israeli Securities Law; |
| • |
Expenses expended by the office holder, including reasonable litigation expenses, and including attorney's fees, in respect of any
proceeding under chapters 8-C, 8-D or 9-A of the Israeli Securities Law or in respect to any monetary sanction; |
| • |
Reasonable litigation expenses, including attorneys’ fees, incurred by such office holder or which were imposed on him by a
court, in proceedings the company instituted against the office holder or that were instituted on the company’s behalf or by another
person, or in a criminal charge from which the office holder was acquitted, or in a criminal proceeding in which the office holder was
convicted of a crime which does not require proof of criminal intent; or |
| • |
Any other liability, payment or expense which the company may indemnify its office holders under the Israeli Company Law, the Israeli
Securities Law or other Israeli law. |
| • |
Undertake in advance to indemnify an office holder, except that with respect to a financial liability imposed on the office holder
by any judgment, settlement or court-approved arbitration award, the undertaking must be limited to types of occurrences, which, in the
opinion of the company’s board of directors, are, at the time of the undertaking, foreseeable due to the company’s activities
and to an amount or standard that the board of directors has determined is reasonable under the circumstances; and |
| • |
Undertake in advance to indemnify an office holder for reasonable litigation expenses, including attorney’s fees, actually
incurred by the office holder as a result of an investigation or proceeding instituted against him or her by a competent authority, provided
that such investigation or proceeding concluded without the filing of an indictment against the office holder or the imposition of any
monetary liability in lieu of criminal proceedings, or concluded without the filing of an indictment against the office holder and a monetary
liability was imposed on the officer holder in lieu of criminal proceedings with respect to a criminal offense that does not require proof
of criminal intent. |
| • |
Undertake in advance to indemnify an office holder for reasonable litigation expenses, including attorneys’ fees, incurred
by such office holder or which were imposed on him by a court, in proceedings the company instituted against the office holder or that
were instituted on the company’s behalf or by another person, or in a criminal charge from which the office holder was acquitted,
or in a criminal proceeding in which the office holder was convicted of a crime which does not require proof of criminal intent.
|
| • |
Retroactively indemnify an office holder of the company. |
| • |
Breach by the office holder of his duty of loyalty, except with respect to insurance coverage or indemnification if the office holder
acted in good faith and had reasonable grounds to assume that the act would not prejudice the company; |
| • |
Breach by the office holder of his duty of care if such breach was committed intentionally or recklessly, unless the breach was committed
only negligently; |
| • |
Any act or omission committed with intent to derive an unlawful personal gain; and |
| • |
Any fine or forfeiture imposed on the office holder. |
|
D. |
Employees |
|
E. |
Share Ownership |
|
F. |
Disclosure of a Registrant’s Action to Recover
Erroneously Awarded Compensation |
|
A. |
Major Shareholders |
|
Name |
Number of
Ordinary Shares
Beneficially Owned(1) |
Percentage of
Ownership(2) |
||||||
|
FIMI Funds (3) |
2,905,202 |
26.6 |
% | |||||
|
MEITAV INVESTMENT HOUSE LTD. (4) |
1,536,936 |
14.0 |
% | |||||
|
Y.D. More Investments Ltd. (5) |
1,213,859 |
11.1 |
% | |||||
| (1) |
Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with
respect to securities. Ordinary shares relating to options and warrants currently exercisable or exercisable within 60 days of the date
of this table are deemed outstanding for computing the percentage of the person holding such securities but are not deemed outstanding
for computing the percentage of any other person. Except as indicated by footnote, and subject to community property laws where applicable,
the persons named in the table above have sole voting and investment power with respect to all shares shown as beneficially owned by them.
|
| (2) |
The percentages shown are based on 10,940,358 ordinary shares issued and outstanding as of December 31, 2024 (net of 274,473 dormant
shares). |
| (3) |
Based on Schedule 13D filed on August 14, 2013, on Schedule 13D/A filed on December 12, 2016 and on Schedule 13D/A filed on
September 3, 2024, FIMI Opportunity V, L.P. (“FIMI Opportunity V”), FIMI Israel Opportunity Five, Limited Partnership
(“FIMI Israel Opportunity V” and together with FIMI Opportunity V, the “FIMI Funds”), FIMI FIVE 2012 Ltd., Shira
and Ishay Davidi Management Ltd. and Mr. Ishay Davidi (collectively, the “Reporting Persons”)
share voting and dispositive power with respect to the 2,905,202 ordinary shares held by the Reporting Persons. FIMI FIVE 2012 Ltd. is
the managing general partner of the FIMI Funds. Shira and Ishay Davidi Management Ltd. controls FIMI FIVE 2012 Ltd. Mr. Ishay Davidi controls
the Shira and Ishay Davidi Management Ltd. and is the Chief Executive Officer of all the entities listed above. The principal business
address of each of the above entities and of Mr. Davidi is c/o FIMI FIVE 2012 Ltd., Alon Towers 2, 94 Yigal Alon St., Tel-Aviv 6789141,
Israel. |
| (4) |
Based on a letter sent to the Company dated January 2, 2025, As of December 31, 2024, Meitav Portfolio Management Ltd, Meitav Provident
Funds & Pension Ltd. share voting and dispositive power with respect to the 1,536,938 ordinary shares held by Meitav Investment House
Ltd. The principal business address of each of the above entities and persons is 1 Jabotinsky St, Bnie Brak, Israel. |
|
(5) |
Based on a Schedule 13G/A filed on January 23, 2025, Y.D. More Investments Ltd, More
Provident Funds & Pension Ltd., More Mutual Funds Management (2013) Ltd., BYM More Investments Ltd., Eli Levy, Yosef Levy, Benjamin
Meirov, Yosef Meirov, Michael Meirov, and Dotan Meirov share voting and dispositive power with respect to the ordinary shares held by
Y.D. More Investments Ltd, More Provident Funds & Pension Ltd. and More Mutual Funds Management (2013) Ltd. The principal business
address of each of the above entities and persons is 2 Ben-Gurion Street, Ramat Gan, Israel. The securities reported herein are held by
More Provident for the benefit of beneficiaries of various provident and pension funds, More Mutual for the benefit of various mutual
funds, and More Investment for the benefit of various portfolio management clients. |
|
B. |
Related Party Transactions |
|
C. |
Interests of Experts and Counsel |
|
A. |
Consolidated Statements and Other Financial Information |
|
B. |
Significant Changes |
|
A. |
Offer and Listing Details |
|
A. |
Plan of Distribution |
|
B. |
Markets |
|
C. |
Selling Shareholders |
|
D. |
Dilution |
|
E. |
Expense of the Issue |
|
A. |
Share Capital |
|
B. |
Memorandum and Articles of Association |
|
C. |
Material Contracts |
|
Material
Contract |
Location
in This Annual Report |
|
2012 Stock Option
Plan |
“ITEM
6.D Directors, Senior Management and Employees – Share Ownership – 2012 Stock Option Plan.” |
|
Amended and Restated
2022 Stock Option Plan |
“ITEM
6.D Directors, Senior Management and Employees – Share Ownership – 2022 Stock Option Plan.” |
|
Amended Compensation
Policy for Directors and Executives |
“ITEM
6.C Directors, Senior Management and Employees – Board Practices – Compensation of Executive Officers and Directors.”
|
|
Indemnification Agreement
of Directors and Officers |
“ITEM
6.C – Directors, Senior Management and Employees – Board Practices – Indemnification and Insurance of Directors and
Officers.” |
|
D. |
Exchange Controls |
|
E. |
Taxation |
| • |
Amortization of purchases of acquired technology and patents over an eight-year period for tax purposes; |
| • |
Amortization of specified expenses incurred in connection with a public issuance of securities over a three-year period for tax purposes;
|
| • |
Right to elect, under specified conditions, to file a consolidated tax return with additional related Israeli Industrial Companies;
and |
| • |
Accelerated depreciation rates on equipment and buildings. |
| • |
An individual citizen or resident of the United States or an individual treated as a U.S. citizen or resident for U.S. federal income
tax purposes; |
| • |
A corporation or other entity taxable as a corporation for U.S. federal income tax purposes created or organized in or under the
laws of the United States, any State or the District of Columbia; |
| • |
An estate, the income of which is subject to U.S. federal income taxation regardless of its source; or |
| • |
Any trust if (A)(i) a court within the United States is able to exercise primary supervision over the administration of the trust
and (ii) one or more United States persons have the authority to control all substantial decisions of the trust, or (B) such trust validly
elects to be treated as a United States person. |
| • |
Insurance companies; |
| • |
Dealers in stocks, securities or currencies; |
| • |
Financial institutions and financial services entities; |
| • |
Real estate investment trusts; |
| • |
Regulated investment companies; |
| • |
Persons that receive ordinary shares in connection with the performance of services; |
| • |
Tax-exempt organizations; |
| • |
Persons that hold ordinary shares as part of a straddle or appreciated financial position or as part of a hedging, conversion or
other integrated instrument; |
| • |
Persons who hold the ordinary shares through partnerships or other pass-through entities; |
| • |
Individual retirement and other tax-deferred accounts; |
| • |
Expatriates of the United States and certain former long-term residents of the United States; |
| • |
Persons liable for the alternative minimum tax; |
| • |
Persons having a “functional currency” other than the U.S. dollar; and |
| • |
Direct, indirect or constructive owners of 10% or more, by voting power or value, of our company. |
| • |
that gain is effectively connected with the conduct by the Non-U.S. Holder of a trade or business in the United States, and, if a
tax treaty applies, is attributable to a permanent establishment or fixed base of the Non-U.S. Holder in the United States; or |
| • |
in the case of any gain realized by an individual Non-U.S. Holder, that holder is present in the United States for 183 days or more
in the taxable year of the sale or exchange, and other conditions are met. |
|
F. |
Dividends and Paying Agents |
|
G. |
Statement by Experts |
|
H. |
Documents on Display |
|
I. |
Subsidiary Information |
|
J. |
Annual Report to Security Holders |
| (a) |
Disclosure Controls and Procedures |
| (b) |
Management's Annual Report on Internal Control over Financial Reporting |
| • |
Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of
the assets of the company; |
| • |
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with
authorizations of management and directors of the company; and |
| • |
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use of disposition of the company’s
assets that could have a material effect on the financial statements. |
| (c) |
Attestation report of independent registered public accounting firm |
|
(d) |
Changes in Internal Control over Financial Reporting
|
|
Year Ended December 31, |
||||||||
|
Services Rendered |
2024 |
2023 |
||||||
|
Audit (1) |
$ |
323,321 |
$ |
396,873 |
||||
|
Tax (2) |
16,000 |
19,571 |
||||||
|
Total |
$ |
339,321 |
$ |
413,444 |
||||
| (1) |
Audit fees are for audit services for each of the years shown in the table, including fees associated with the annual audit and reviews
of our quarterly financial results, consultations on various accounting issues and audit services provided in connection with other statutory
or regulatory filings. |
| (2) |
Tax fees relate to professional services rendered for tax compliance and tax advice. These services include assistance regarding
international and Israeli taxation. |
| o |
The securities issued amount to 20% or more of our outstanding voting rights before the issuance; |
| o |
Some or all of the consideration is other than cash or listed securities or the transaction is not in accordance with market terms;
and |
| o |
The transaction will increase the relative holdings of a shareholder that holds 5% or more of our outstanding share capital or voting
rights or that it will cause any person to become, as a result of the issuance, a holder of more than 5% of our outstanding share capital
or voting rights. |
1.1 | Memorandum of Association of the Registrant (1) |
101.INS | Inline XBRL Instance Document. |
101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
101.DEF | Inline XBRL Taxonomy Definition Linkbase Document. |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
| (1) | Filed as an exhibit to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 1992, and incorporated herein by reference. |
| (2) | Filed as Exhibit 2.1 to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2022, and incorporated herein by reference. |
| (3) | Filed as an exhibit to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2012, and incorporated herein by reference. |
| (4) | Filed as an exhibit to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2013, and incorporated herein by reference. |
TAT TECHNOLOGIES LTD. | ||
By: | /s/ Ehud Ben-Yair | |
Ehud Ben-Yair | ||
Chief Financial Officer (Principal Financial and Accounting Officer) | ||
Date: March 26, 2025 | ||
|
Page
|
|
|
Report of Independent Registered Public Accounting Firm (PCAOB ID Number
|
F-2 - F-3
|
|
F-4 - F-5
|
|
|
F-6 - F-7
|
|
|
F-8
|
|
|
F-9
|
|
|
F-10 - F-11
|
|
|
F-12 - F-51
|

| Kesselman & Kesselman, 146 Derech Menachem Begin St. Tel-Aviv 6492103, Israel, |
| P.O Box 7187 Tel-Aviv 6107120, Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il |
|
|
/s/
|
|
March 26, 2025
|
Certified Public Accountants (Isr.)
|
|
A member firm of PricewaterhouseCoopers International Limited
|
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Accounts receivable, net of allowance for credit losses of $
|
|
|
||||||
|
Restricted deposit
|
|
|
||||||
|
Other current assets and prepaid expenses
|
|
|
||||||
|
Inventory
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
NON-CURRENT ASSETS:
|
||||||||
|
Restricted deposit
|
|
|
||||||
|
Investment in affiliates
|
|
|
||||||
|
Funds in respect of employee rights upon retirement
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Property, plant and equipment, net
|
|
|
||||||
|
Operating lease right of use assets
|
|
|
||||||
|
Intangible assets, net
|
|
|
||||||
|
Total non-current assets
|
|
|
||||||
|
Total assets
|
|
|
||||||
F - 4
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
LIABILITIES AND SHAREHOLDERS 'EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Current maturities of long-term loans
|
$
|
|
$
|
|
||||
|
Short term loans
|
|
|
||||||
|
Accounts payable
|
|
|
||||||
|
Accrued expenses and other
|
|
|
||||||
|
Current maturities of operating lease liabilities
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
NON-CURRENT LIABILITIES:
|
||||||||
|
Long-term loans
|
|
|
||||||
|
Liability in respect of employee rights upon retirement
|
|
|
||||||
|
Operating lease liabilities
|
|
|
||||||
|
Total non-current liabilities
|
|
|
||||||
|
COMMITMENTS AND CONTINGENCIES (NOTE 11)
|
||||||||
|
Total liabilities
|
|
|
||||||
|
SHAREHOLDERS 'EQUITY:
|
||||||||
|
Ordinary shares of NIS
Authorized:
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Treasury shares, at cost,
|
(
|
)
|
(
|
)
|
||||
|
Accumulated other comprehensive income
|
(
|
)
|
|
|||||
|
Retained earnings
|
|
|
||||||
|
Total shareholders' equity
|
|
|
||||||
|
Total liabilities and shareholders' equity
|
|
|
||||||
F - 5
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Revenue:
|
||||||||||||
|
Products
|
$
|
|
$
|
|
$
|
|
||||||
|
Services
|
|
|
|
|||||||||
|
|
|
|
||||||||||
|
Cost of revenue, net:
|
||||||||||||
|
Products
|
|
|
|
|||||||||
|
Services
|
|
|
|
|||||||||
|
|
|
|
||||||||||
|
Gross profit
|
|
|
|
|||||||||
|
Operating expenses:
|
||||||||||||
|
Research and development, net
|
|
|
|
|||||||||
|
Selling and marketing, net
|
|
|
|
|||||||||
|
General and administrative, net
|
|
|
|
|||||||||
|
Other income
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Restructuring expenses, net
|
|
|
||||||||||
|
|
|
|
||||||||||
|
Operating income (loss)
|
|
|
(
|
)
|
||||||||
|
Interest expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Other financial income (expenses), net
|
(
|
)
|
|
|
||||||||
|
Income profit (loss) before taxes on income
|
|
|
(
|
)
|
||||||||
|
Taxes on income
|
|
|
|
|||||||||
|
Profit (Loss) before share of equity investment
|
|
|
(
|
)
|
||||||||
|
Share in profit of equity investment of affiliated companies
|
|
|
|
|||||||||
|
Net income (loss)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
F - 6
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Net income (loss)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Net income (loss) per share basic
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Net income (loss) per share diluted
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Weighted average number of shares outstanding:
|
||||||||||||
|
Basic
|
|
|
|
|||||||||
|
Diluted
|
|
|
|
|||||||||
F - 7
| Year ended December 31, | ||||||||||||
| 2024 |
2023
|
2022 | ||||||||||
|
Net income (loss)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Other comprehensive income (loss), net
|
||||||||||||
|
Net unrealized gains (losses) from derivatives
|
(
|
)
|
|
(
|
)
|
|||||||
|
Change in foreign currency translation Adjustments
|
(
|
)
|
|
|
||||||||
|
Reclassification adjustments for loss from derivatives included in net income
|
|
|
|
|||||||||
|
Total other comprehensive income (loss)
|
(
|
)
|
|
(
|
)
|
|||||||
|
Total comprehensive income (loss)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
F - 8
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
|
Ordinary shares
|
Additional paid-in capital
|
Accumulated
other comprehensive income (loss)
|
Treasury shares
|
Retained earnings
|
Total equity
|
|||||||||||||||||||||||
|
Number of shares issued
|
Amount
|
|||||||||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2021 |
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||||
|
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2022:
|
||||||||||||||||||||||||||||
|
Comprehensive income
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||||
|
Exercise of Options
|
|
|
|
|
||||||||||||||||||||||||
|
Share based compensation
|
|
|
||||||||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||||
|
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2023:
|
||||||||||||||||||||||||||||
|
Comprehensive income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Exercise of Options
|
|
|
|
|
|
|
||||||||||||||||||||||
|
Issuance of common shares net of issuance costs of $
|
|
|
|
|
|
|
||||||||||||||||||||||
|
Share based compensation
|
|
|
|
|
||||||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||||
|
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2024:
|
||||||||||||||||||||||||||||
|
Comprehensive income(loss)
|
-
|
|
|
(
|
)
|
|
|
|
||||||||||||||||||||
|
Exercise of Options
|
|
|
(
|
)
|
|
|
|
|
||||||||||||||||||||
|
Cancel of shares par value (see note 12a)
|
(
|
)
|
|
|
|
|
|
|||||||||||||||||||||
|
Issuance of common shares net of issuance costs of $
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Share based compensation
|
|
|
|
|
|
|
||||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2024
|
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||||
F - 9
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||||||
|
Net income (loss)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
||||||||||||
|
Depreciation and amortization
|
|
|
|
|||||||||
|
Loss (gain) from change in fair value of derivatives
|
|
(
|
)
|
|
||||||||
|
Change in funds in respect of employee rights upon retirement
|
|
|
|
|||||||||
|
Net change in operating right of use asset and operating lease liability
|
|
|
(
|
)
|
||||||||
|
Non cash financial expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Decrease in restructuring plan provision
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Change in allowance for credit losses
|
|
(
|
)
|
|
||||||||
|
Share in results of affiliated companies
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Share based compensation
|
|
|
|
|||||||||
|
Liability in respect of employee rights upon retirement
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Capital gain from sale of property, plant and equipment
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Deferred income taxes, net
|
|
|
|
|||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
Increase in trade accounts receivable
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Increase in other current assets and prepaid expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Increase in inventory
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Increase (decrease) in trade accounts payable
|
|
(
|
)
|
|
||||||||
|
Increase in accrued expenses and other
|
|
|
|
|||||||||
|
Net cash provided by (used in) operating activities from continued operation
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||||||
|
Proceeds from sale of property and equipment
|
|
|
|
|||||||||
|
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Purchase of intangible assets
|
|
(
|
)
|
|
||||||||
|
Net cash used in investing activities from continued operations
|
$
|
(
|
)
|
$
|
( |
)
|
$
|
(
|
)
|
|||
F - 10
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||||||
|
Repayments of long-term loans
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net change in short term credit from banks
|
(
|
)
|
|
|
||||||||
|
Proceeds from long-term loans received
|
|
|
|
|||||||||
|
Proceeds from issuance of common shares, net
|
|
|
|
|||||||||
|
Exercise of options
|
|
|
|
|||||||||
|
Net cash provided by financing activities from continued operations
|
$
|
|
$
|
|
$
|
|
||||||
|
Net increase (decrease) in cash and cash equivalents and restricted cash
|
(
|
) |
|
(
|
)
|
|||||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
|
|
|
|||||||||
|
Cash and cash equivalents and restricted cash at end of period
|
|
|
|
|||||||||
|
SUPPLEMENTARY INFORMATION ON INVESTING ACTIVITIES NOT INVOLVING CASH FLOW:
|
||||||||||||
|
Purchase of property, plant and equipment on credit
|
|
|
|
|||||||||
|
Additions of operating lease right-of-use assets and operating lease liabilities
|
|
|
|
|||||||||
|
Reclassification of inventory to property, plant and equipment
|
|
|
|
|||||||||
|
Capital contribution to equity method investee
|
|
|
|
|||||||||
|
Supplemental disclosure of cash flow information:
|
||||||||||||
|
Interest paid
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Income taxes received (paid), net
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
F - 11
|
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
|
|
|
|
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
U.S. dollars in thousands
|
| NOTE 1 - |
GENERAL
|
| a. |
TAT Technologies Ltd., (“TAT” or the “Company”) an Israeli corporation, incorporated in 1985, is a leading provider of solutions and services to the aerospace and defense industries, focused on the following four segments: (i) original equipment manufacturing (“OEM”) of heat transfer solutions and aviation accessories mainly through our Kiryat Gat facility ; (ii) MRO (“Maintenance Repair and Overhaul”) services for heat transfer components and OEM of heat transfer solutions through Limco Airepair Inc our wholly-owned subsidiary; (iii) MRO services for aviation components (mainly Auxiliary Power Unit “APU” and Landing Gear “LG”) through Piedmont Aviation Component Services LLC our wholly-owned subsidiary; and (iv) overhaul and coating of jet engine components through Turbochrome our wholly-owned subsidiary. TAT targets the commercial aerospace (serving a wide range of types and sizes of commercial and business jets), military aerospace and ground defense sectors. TAT’s shares are listed on both the NASDAQ (TATT) and Tel-Aviv Stock Exchange.
|
| b. |
During 2024, global conflicts continue to create volatility in global financial and energy markets and contribute to supply chain shortages adding to the inflationary pressures in the global economy. This capabilities lead to higher material and labor costs, and as a result the company made a decision to remain in higher inventory levels . The company actively collaborate with its suppliers to minimize impacts of supply shortages on manufacturing and MRO services.
|
| c. |
In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas. In addition, since the commencement of these events, there have been continued hostilities along Israel’s northern border with Lebanon (with the Hezbollah terror organization; ), Israel’s southern border with the Gaza Strip (with the Hamas terrorist organization) and on other fronts from various extremist groups in region, such as the Houthis in Yemen and various rebel militia groups in Syria and Iraq. Further, on April 13, 2024, and on October 1, 2024, Iran launched a series of drone and missile strikes against Israel. As of December 31, 2024 a ceasefire agreement has been reached between Israel and Lebanon. To date the Company’s operations and financial results have not been materially affected. The Company expects that the current conflict in the Gaza Strip, Lebanon and the security escalation in Israel will not have a material impact on its business results in the short term. However, since this is an event beyond the Company’s control and may impact our Israeli activity, its continuation or cessation may affect our expectations. The Company continues to monitor its ongoing activities and will make any needed adjustments to ensure continuity of its business, while supporting the safety and well-being of its employees. In the year ended on December 31, 2024 the Group’s activity in Israel contributed $
|
| d. |
TAT has the following wholly owned subsidiaries: Limco-Piedmont Inc. (“Limco-Piedmont”), and Turbochrome Ltd. (“Turbochrome”). Additionally, the Company holds
|
F - 12
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 2 -
|
SIGNIFICANT ACCOUNTING POLICIES
|
| a. |
Basis of Presentation
|
| b. |
Use of estimates in the preparation of financial statement
|
| c. |
Functional currency
|
F - 13
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 2 - |
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| d. |
Principles of consolidation
|
|
e.
|
Cash and Cash equivalents
|
|
2024
|
2023
|
|||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Restricted deposit short term
|
|
|
||||||
|
Restricted deposit long term
|
|
|
||||||
|
Total cash and cash equivalents and restricted cash equivalents
|
$
|
|
$
|
|
||||
| f. |
Accounts receivable, net
|
F - 14
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 2 - |
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| g. |
Inventory
|
| h. |
Property, plant and equipment
|
|
Years
|
|||
|
Buildings
|
|
||
|
Leasehold improvements
|
|
||
|
Machinery and equipment
|
|
||
|
Motor vehicles
|
|
||
|
Office furniture and equipment
|
|
||
|
Internal use software
|
|
F - 15
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 2 - |
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| h. |
Property, plant and equipment (cont.)
|
| i. |
Government grants:
|
| j. |
Investment in affiliates and share in results of equity investment of affiliated companies
|
F - 16
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 2 - |
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| j. |
Investment in affiliates and share in results of equity investment of affiliated companies (cont.)
|
| k. |
Leases
|
| l. |
Identified intangible assets
|
F - 17
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 2 - |
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| m. |
Impairment of long-lived assets
|
| n. |
Treasury Shares
|
| o. |
Revenue Recognition
|
F - 18
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
|
o.
|
Revenue recognition (cont.)
|
| p. |
Warranty costs
|
| q. |
Research and development
|
F - 19
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| r. |
Fair value measurement
|
| s. |
Concentrations of credit risk
|
F - 20
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| s. | Concentrations of credit risk (cont.) |
| t. |
Income taxes
|
F - 21
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| t. |
Income taxes (cont.)
|
| u. |
Earnings per share
|
| v. |
Share-based compensation
|
| w. |
Comprehensive income (loss)
|
F - 22
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| x. |
Contingencies
|
| y. |
Derivatives and hedging
|
F - 23
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (CONT)
|
| z. |
Recently Issued Accounting Principles:
|
| aa. |
Recently adopted accounting pronouncements:
|
F - 24
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 3 - |
INVENTORY
|
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
Raw materials and components
|
$
|
|
$
|
|
||||
|
Work in progress
|
|
|
||||||
|
Finished goods
|
|
|
||||||
|
Total inventory
|
$
|
|
$
|
|
||||
|
NOTE 4 -
|
INVESTMENT IN AFFILIATES
|
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
Balance sheets:
|
||||||||
|
Current assets
|
$
|
|
$
|
|
||||
|
Non-current assets
|
|
|
||||||
|
Current liabilities
|
|
|
||||||
F - 25
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 4 -
|
INVESTMENT IN AFFILIATES (CONT)
|
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Statements of operation:
|
||||||||||||
|
Revenues
|
$
|
|
$
|
|
$
|
|
||||||
|
Gross profit (loss)
|
|
|
|
|||||||||
|
Net income (loss)
|
|
|
|
|||||||||
|
Net income (losses) attributable to the Company
|
|
|
|
|||||||||
|
NOTE 5 -
|
PROPERTY, PLANT AND EQUIPMENT, NET
|
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
Cost:
|
||||||||
|
Land and buildings
|
$
|
|
$
|
|
||||
|
Leasehold improvements
|
|
|
||||||
|
Machinery and equipment
|
|
|
||||||
|
Motor vehicles
|
|
|
||||||
|
Office furniture and equipment
|
|
|
||||||
|
Internal use software
|
|
|
||||||
|
|
|
|||||||
|
Less: Accumulated depreciation and amortization
|
|
|
||||||
|
Depreciated cost
|
$
|
|
$
|
|
||||
|
NOTE 6 -
|
LEASES
|
F - 26
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 6 -
|
LEASES (CONT)
|
|
Year ended
December 31,
2024
|
Year ended
December 31,
2023
|
|||||||
|
Operating lease expenses
|
|
|
||||||
|
Year ended December 31,
2024
|
Year ended December 31,
2023
|
|||||||
|
Operating cash flows from operating leases
|
|
|
||||||
|
Right-of-use assets obtained in exchange for lease obligations (non-cash)
|
|
|
||||||
|
December 31,
2024
|
December 31,
2023
|
|||||||
|
Operating Leases
|
||||||||
|
Operating lease right-of-use assets
|
|
|
||||||
|
Current operating lease liabilities
|
|
|
||||||
|
Non-current operating lease liabilities
|
|
|
||||||
|
Total operating lease liabilities
|
|
|
||||||
|
Weighted Average Remaining Lease Term
|
||||||||
|
Operating leases - Israel
|
|
|
||||||
|
Operating leases – United States
|
|
|
||||||
|
Weighted Average discount rate
|
||||||||
|
Operating leases - Israel
|
|
%
|
|
%
|
||||
|
Operating leases – United States
|
|
%
|
|
%
|
||||
F - 27
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 6 -
|
LEASES (CONT)
|
|
Year
|
Amount
|
|||
|
2025
|
|
|||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029 and after
|
|
|||
|
Total lease payments
|
$
|
|
||
|
Less imputed interest
|
(
|
)
|
||
|
Total
|
$
|
|
||
|
NOTE 7 -
|
INTANGIBLE ASSETS
|
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
Commercial license
|
||||||||
|
Cost
|
$
|
|
$
|
|
||||
|
Accumulated amortization
|
(
|
)
|
(
|
)
|
||||
|
Amortized cost
|
$
|
|
$
|
|
||||
F - 28
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 8 -
|
LONG-TERM LOANS AND CREDIT LINES
|
|
Total balance amount as of
year ended December 31
|
|||||||||||||||
|
2024
|
2023
|
Rate
|
Duration
|
||||||||||||
| Israel | |||||||||||||||
|
Gov guaranteed loans (see a)
|
$
|
|
$
|
|
|
%(*)
|
|
||||||||
|
Commercial loans (see b)
|
|
|
|
%(*)
|
|
||||||||||
|
USA
|
|||||||||||||||
|
Commercial loans (see c)
|
|
|
|
%
|
|
||||||||||
|
Line of Credit (see d)
|
|
|
|
%(*)
|
Revolving
|
||||||||||
|
Machinery finance loans (see e)
|
|
|
|
%
|
|
||||||||||
|
$
|
|
$
|
|
||||||||||||
| a. |
TAT received several loans from the Israeli banks (with a guaranty from the Israeli government) during 2020 and 2021 in an aggregate amount of $
|
| b. |
In March 2022, TAT received a loan from a commercial bank in the amount of $
|
| c. |
In May 2022 TAT a US subsidiary received a loan from a commercial bank in the US in the amount of $
|
| d. |
In February 2022 TAT a US subsidiary received a credit line from a US commercial bank in the amount of $
|
F - 29
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 8 -
|
LONG-TERM LOANS AND CREDIT LINES (CONT)
|
| e. |
TAT subsidiary received loans from Machinery Finance in the total amount of $
|
| f. |
By June 2023 TAT secured another short-term line of credit from an Israeli bank for $
|
|
Year
|
Amount
|
|||
|
2025
|
|
|||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029 and after
|
|
|||
|
$
|
|
|||
|
Fair value
|
Carrying Amount
|
|||||||||||||||
|
2024
|
2023
|
2024
|
2023
|
|||||||||||||
|
The TAT subsidiary loan at c above
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
The other TAT subsidiary loan at c above
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
F - 30
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 9 -
|
ACCRUED EXPENSES AND OTHER
|
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
Employees and payroll accruals
|
$
|
|
$
|
|
||||
|
Accrued expenses
|
|
|
||||||
|
Authorities
|
|
|
||||||
|
*Contract liabilities
|
|
|
||||||
|
Warranty provision
|
|
|
||||||
|
Accrued royalties
|
|
|
||||||
|
Provision for restructuring plan
|
|
|
||||||
|
Other
|
|
|
||||||
|
$
|
|
$
|
|
|||||
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
Opening balance
|
|
|
||||||
|
Additions
|
|
|
||||||
|
Revenue recognized
|
(
|
)
|
(
|
)
|
||||
|
Closing balance
|
|
|
||||||
| NOTE 10 - |
LONG-TERM EMPLOYEE-RELATED OBLIGATIONS
|
F - 31
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 10 - |
LONG-TERM EMPLOYEE-RELATED OBLIGATIONS (CONT)
|
|
Year
|
Amount
|
|||
|
2025
|
$
|
|
||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
|||
|
Thereafter (through 2033)
|
|
|||
|
Total
|
$
|
|
||
F - 32
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 11 -
|
COMMITMENTS AND CONTINGENCIES
|
| a. |
Commissions arrangements:
|
| b. |
Royalty commitments:
|
|
c.
|
Guarantees:
|
| (1) |
In order to secure TAT's liability to the Israeli customs, the Company provided bank guarantees in amounts of
|
| (2) |
TAT has provided bank guarantee to office lessor in amounts of
|
| (3) |
Turbochrome has provided a bank guarantee to the local planning and building committee in amounts of
|
|
d.
|
Litigation:
|
F - 33
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 12 -
|
SHAREHOLDERS' EQUITY
|
| a. |
TAT's Ordinary shares confer upon their holders' voting rights, the right to receive dividends, if declared, and any amounts payable upon the dissolution, liquidation or winding up of the affairs of TAT.
|
| b. |
Stock option plans:
|
F - 34
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 12 -
|
SHAREHOLDERS' EQUITY (CONT)
|
| b. |
Stock option plans (cont.):
|
F - 35
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 12 -
|
SHAREHOLDERS' EQUITY (CONT)
|
| b. |
Stock option plans (cont.):
|
|
Grant date
|
Description
|
Number of options
|
Exercise price
|
|||||||
|
March 22, 2022
|
2012 Plan
|
|
$
|
|||||||
|
May, 2022
|
2012 Plan
|
|
$
|
|||||||
|
December 1, 2022
|
2022 Plan
|
|
$
|
|||||||
|
January 9, 2023
|
2022 Plan
|
|
|
|||||||
|
February 10, 2023
|
2022 Plan
|
|
|
|||||||
|
March 29, 2023
|
2012 Plan
|
|
|
|||||||
|
May 30, 2023
|
2022 Plan
|
|
|
|||||||
|
August 28, 2023
|
2022 Plan
|
|
|
|||||||
|
March 6, 2024
|
2022 Plan
to senior executive
|
|
$
|
|||||||
|
2024
|
2023
|
2022
|
|||||||
|
Expected stock price volatility
|
|
|
|
|
|
|
|||
|
Expected option life (in years)
|
|
|
|
||||||
|
Risk free interest rate
|
|
|
|
|
|
||||
|
Dividend yield
|
|
|
|
|
|
|
F - 36
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 12 -
|
SHAREHOLDERS' EQUITY (CONT)
|
| b. |
Stock option plans (cont.):
|
|
Year ended December 31,
|
Year ended December 31,
|
Year ended December 31,
|
||||||||||||||||||||||
|
2024
|
2023
|
2022
|
||||||||||||||||||||||
|
Number
of
options
|
Weighted
average
exercise
price
|
Number
of
options
|
Weighted
average
exercise
price
|
Number
of
options
|
Weighted
average
exercise
price
|
|||||||||||||||||||
|
Outstanding at the beginning of the year
|
|
$
|
|
|
$
|
|
|
$
|
|
|||||||||||||||
|
Granted
|
|
|
|
|
|
|
||||||||||||||||||
|
Forfeited
|
(
|
)
|
|
(
|
)
|
|
||||||||||||||||||
|
Exercised*
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||
|
Outstanding at the end of the year
|
|
|
|
|
|
|
||||||||||||||||||
|
Exercisable at the end of the year
|
|
|
|
|
|
$
|
|
|||||||||||||||||
F - 37
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 12 -
|
SHAREHOLDERS' EQUITY (CONT)
|
|
awards outstanding
|
awards exercisable
|
|||||||||||||||||
|
Exercise price
|
Number of awards outstanding at the end of the year
|
Weighted
average
remaining contractual life (years)
|
Number of awards exercisable at the end of year
|
Weighted
average remaining contractual life (years)
|
||||||||||||||
|
|
$
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
||||||||||||||||
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
||||||||||||||||
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Cost of revenue
|
|
|
|
|||||||||
|
Research and development
|
|
|
|
|||||||||
|
Sales and marketing
|
|
|
|
|||||||||
|
General and administrative
|
|
|
|
|||||||||
|
|
||||||||||||
|
Total stock-based compensation
|
|
|
|
|||||||||
F - 38
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 13 -
|
EARNINGS PER SHARE (“EPS”)
|
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Numerator for EPS:
|
||||||||||||
|
Net Income (loss)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Denominator for EPS:
|
||||||||||||
|
Weighted average shares outstanding – basic
|
|
|
|
|||||||||
|
Dilutive shares
|
|
|
|
|||||||||
|
Weighted average shares outstanding – diluted
|
|
|
|
|||||||||
|
EPS:
|
||||||||||||
|
Basic
|
$
|
|
$
|
|
$
|
(
|
) | |||||
|
Diluted
|
$
|
|
$
|
|
$
|
(
|
) | |||||
| NOTE 14 - |
TAXES ON INCOME
|
| a. |
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 ("the Law"):
|
F - 39
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 14 - |
TAXES ON INCOME (CONT)
|
| a. |
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 ("the Law") (cont.):
|
| b. |
Corporate tax rate in Israel
|
F - 40
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 14 - |
TAXES ON INCOME (CONT)
|
| c. |
U.S. subsidiaries
|
| d. |
Tax assessments
|
|
TAT’s income tax assessments are considered final through 2018.
|
|
Turbochrome income tax assessments are considered final through 2018.
|
|
Limco-Piedmont income tax assessments are considered final through 2019.
|
| e. |
Income tax reconciliation:
|
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Income (loss) before taxes on income (tax benefit) from continued operations reported in the statements of income
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Statutory tax rate in Israel
|
|
%
|
|
%
|
|
%
|
||||||
|
Theoretical taxes on income (tax benefit)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Decrease in taxes on income resulting from:
|
||||||||||||
|
Tax adjustment for foreign subsidiaries subject to a different tax rate
|
(
|
)
|
(
|
)
|
(
|
) | ||||||
|
Reduced tax rate on income derived from "Preferred Enterprises" plans
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Release of valuation allowance
|
(
|
)
|
|
|
||||||||
|
Reduced deferred tax asset from expecting utilization of carryforward losses
|
|
|
|
|||||||||
|
Tax in respect of prior years
|
-
|
|
|
|||||||||
|
Permanent differences
|
|
|
|
|||||||||
|
Other adjustments
|
|
(
|
)
|
|
||||||||
|
Taxes on income as reported in the statements of income
|
$
|
|
$
|
|
$
|
|
||||||
F - 41
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 14 - |
TAXES ON INCOME (CONT)
|
| f. |
Income (loss) before taxes on income (tax benefit) is comprised as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Domestic (Israel)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Foreign (United States)
|
|
|
(
|
)
|
||||||||
|
$
|
|
$
|
|
$
|
(
|
)
|
||||||
| g. |
Taxes on income (tax benefit) included in the statements of income:
|
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Current:
|
||||||||||||
|
Domestic (Israel)
|
$
|
|
$
|
|
$
|
|
||||||
|
Foreign (United States)
|
|
|
|
|||||||||
|
|
|
|
||||||||||
|
Deferred:
|
||||||||||||
|
Domestic (Israel)
|
(
|
)
|
|
|
||||||||
|
Foreign (United States)
|
|
|
(
|
)
|
||||||||
|
|
|
|
||||||||||
|
$
|
|
$
|
|
$
|
|
|||||||
F - 42
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 14 -
|
TAXES ON INCOME (CONT)
|
| h. |
Deferred income taxes:
|
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Provisions for employee benefits
|
$
|
|
$
|
|
||||
|
Inventory
|
|
|
||||||
|
Capital tax losses carryforward
|
|
|
||||||
|
Net operating losses carryforward
|
|
|
||||||
|
R&D expenses
|
|
|
||||||
|
Other
|
|
|
||||||
|
Deferred tax assets, before valuation allowance
|
$
|
|
$
|
|
||||
|
Valuation allowance
|
(
|
)
|
(
|
)
|
||||
|
Deferred tax assets, net
|
|
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Property, plant and equipment
|
(
|
)
|
(
|
)
|
||||
|
Intangible assets
|
(
|
)
|
(
|
)
|
||||
|
Other temporary differences deferred tax liabilities
|
(
|
)
|
|
|||||
|
Deferred tax liabilities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Net
|
|
|
||||||
|
Balance, December 31, 2021
|
$
|
|
||
|
Deductions during the year
|
(
|
)
|
||
|
Balance, December 31,2022
|
$
|
|
||
|
Deductions during the year
|
(
|
)
|
||
|
Balance, December 31,2023
|
$
|
|
||
|
VA Release during the year
|
(
|
)
|
||
|
Deductions during the year
|
(
|
)
|
||
|
Balance, December 31,2024
|
$
|
|
F - 43
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 14 - |
TAXES ON INCOME (CONT)
|
| h. |
Deferred income taxes (cont.):
|
| NOTE 15 - |
SEGMENT INFORMATION
|
| a. |
Segment Activities Disclosure:
|
| - |
OEM of heat transfer solutions and aviation accessories primarily include the design, development and manufacture of (i) broad range of heat transfer solutions, such as pre-coolers heat exchangers and oil/fuel hydraulic heat exchangers, used in mechanical and electronic systems on board of commercial, military and business aircraft; (ii) environmental control and power electronics cooling systems installed on board aircraft in and ground applications; and (iii) a variety of other mechanical aircraft accessories and systems such as pumps, valves, and turbine power units.
|
F - 44
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 15 - |
SEGMENT INFORMATION (CONT)
|
| a. |
Segment Activities Disclosure (cont):
|
| - |
MRO Services for heat transfer components and OEM of heat transfer solutions primarily include the MRO of heat transfer components and to a lesser extent, the manufacturing of certain heat transfer solutions. TAT’s Limco subsidiary operates an FAA-certified repair station, which provides heat transfer MRO services for airlines, air cargo carriers, maintenance service centers and the military.
|
| - |
MRO services for aviation components include the MRO of APUs, landing gears and other aircraft components, as well as APU lease activity. TAT’s Piedmont subsidiary operates an FAA-certified repair station, which provides aircraft component MRO services for airlines, air cargo carriers, maintenance service centers and the military.
|
| - |
TAT’s activities in the area of overhaul and coating of jet engine components includes the overhaul and coating of jet engine components, including turbine vanes and blades, fan blades, variable inlet guide vanes and afterburner flaps.
|
F - 45
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 15 - |
SEGMENT INFORMATION (CONT)
|
| b. |
Segments statement operations disclosure:
|
|
Year ended December 31, 2024
|
||||||||||||||||||||||||
|
OEM of Heat Transfer Solutions and Aviation Accessories
|
MRO Services for heat transfer components and OEM of heat transfer solutions
|
MRO services for Aviation Components and Lease
|
Overhaul and coating of jet engine components
|
Elimination of inter-Company sales
|
Consolidated
|
|||||||||||||||||||
|
Revenues external
|
$
|
|
$
|
|
$
|
|
$
|
|
|
$
|
|
|||||||||||||
|
Revenues internal
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Cost of revenues
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Gross profit
|
|
|
|
|
|
|
||||||||||||||||||
|
Research and development
|
|
|
|
|
|
|
||||||||||||||||||
|
Selling and marketing
|
|
|
|
|
|
|
||||||||||||||||||
|
General and administrative
|
|
|
|
|
|
|
||||||||||||||||||
|
Other segment expenses (income)*
|
|
|
* (
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
|
Operating income
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||
|
Financial expenses, net
|
||||||||||||||||||||||||
|
(
|
)
|
|||||||||||||||||||||||
|
Profit before tax benefits
|
$
|
|
||||||||||||||||||||||
F - 46
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 15 -
|
SEGMENT INFORMATION (CONT)
|
| b. |
Segments statement operations disclosure (cont.)
|
|
Year ended December 31, 2023
|
||||||||||||||||||||||||
|
OEM of Heat Transfer Solutions and Aviation Accessories
|
MRO Services for heat transfer components and OEM of heat transfer solutions
|
MRO services for Aviation Components and Lease
|
Overhaul and coating of jet engine components
|
Elimination of inter-Company sales
|
Consolidated
|
|||||||||||||||||||
|
Revenues external
|
$
|
|
$
|
|
$
|
|
$
|
|
|
$
|
|
|||||||||||||
|
Revenues internal
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Cost of revenues
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Gross profit
|
|
|
|
|
|
|
||||||||||||||||||
|
Research and development
|
|
|
|
|
|
|
||||||||||||||||||
|
Selling and marketing
|
|
|
|
|
|
|
||||||||||||||||||
|
General and administrative
|
|
|
|
|
|
|
||||||||||||||||||
|
Other segment expenses (income)
|
|
(
|
)
|
*(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||
|
Operating income
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||
|
Financial expenses, net
|
(
|
) | ||||||||||||||||||||||
|
Profit before tax benefits
|
$
|
|
||||||||||||||||||||||
F - 47
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 15 - |
SEGMENT INFORMATION (CONT)
|
| b. |
Segments statement operations disclosure (cont.)
|
|
Year ended December 31, 2022
|
||||||||||||||||||||||||
|
OEM of Heat Transfer Solutions and Aviation Accessories
|
MRO Services for heat transfer components and OEM of heat transfer solutions
|
MRO services for Aviation Components and lease
|
Overhaul and coating of jet engine components
|
Elimination of inter-Company sales
|
Consolidated
|
|||||||||||||||||||
|
Revenues external
|
$
|
|
$
|
|
$
|
|
$
|
|
|
$
|
|
|||||||||||||
|
Revenues internal
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Cost of revenues
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Gross profit (loss)
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Research and development
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Selling and marketing
|
|
|
|
|
|
|
||||||||||||||||||
|
General and administrative
|
|
|
|
|
|
|
||||||||||||||||||
|
Other segment expenses (income)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||
|
Restructuring expenses, net
|
|
|
|
|
|
|
||||||||||||||||||
|
Operating income (loss)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||||||
|
Financial expenses, net
|
|
|||||||||||||||||||||||
|
Profit (loss) before taxes on income
|
$
|
(
|
)
|
|||||||||||||||||||||
F - 48
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
| NOTE 15 - |
SEGMENT INFORMATION (CONT)
|
| c. |
The following financial information identifies the assets, depreciation and amortization, and capital expenditures to segments:
|
|
Year ended December 31, 2024
|
||||||||||||||||||||||||
|
OEM of Heat Transfer Solutions and Aviation Accessories
|
MRO Services for heat transfer components and OEM of heat transfer solutions
|
MRO services for Aviation Components and Lease
|
Overhaul and coating of jet engine components
|
Amounts not allocated to segments
|
Consolidated
|
|||||||||||||||||||
|
Total assets
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Depreciation and amortization
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Expenditure for segment assets
|
|
|
|
|
|
|||||||||||||||||||
|
Year ended December 31, 2023
|
||||||||||||||||||||||||
|
OEM of Heat Transfer Solutions and Aviation Accessories
|
MRO Services for heat transfer components and OEM of heat transfer solutions
|
MRO services for Aviation Components and Lease
|
Overhaul and coating of jet engine components
|
Amounts not allocated to segments
|
Consolidated
|
|||||||||||||||||||
|
Total assets
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Depreciation and amortization
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
|
Expenditure for segment assets
|
|
|
|
|
|
|||||||||||||||||||
F - 49
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 16 -
|
ENTITY-WIDE DISCLOSURE
|
| a. |
Total revenues - by geographical location were attributed according to customer residential country as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Total revenues
|
Total revenues
|
Total revenues
|
||||||||||
|
Sale of products
|
||||||||||||
|
Israel
|
$
|
|
$
|
|
$
|
|
||||||
|
United States
|
|
|
|
|||||||||
|
Other
|
|
|
|
|||||||||
|
$
|
|
$
|
|
$
|
|
|||||||
|
Year ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Total revenues
|
Total revenues
|
Total revenues
|
||||||||||
|
Sale of Services
|
||||||||||||
|
Israel
|
$
|
|
$
|
|
$
|
|
||||||
|
United States
|
|
|
|
|||||||||
|
Other
|
|
|
|
|||||||||
|
$
|
|
$
|
|
$
|
|
|||||||
| b. |
Total long-lived assets - by geographical location were as follows:
|
|
December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Israel
|
$
|
|
$
|
|
$
|
|
||||||
|
United States
|
|
|
|
|||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
||||||
| c. |
Major Customers
|
F - 50
TAT TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
NOTE 17 -
|
SUPPLEMENTAL CONSOLIDATED BALANCE SHEETS INFORMATION
|
|
Warranty provision
|
Provision for current expected credit losses
|
|||||||
|
Balance, as of December 31, 2021
|
$
|
|
$
|
|
||||
|
Additions
|
|
|
||||||
|
Deductions
|
|
(
|
)
|
|||||
|
Balance, as of December 31, 2022
|
$
|
|
$
|
|
||||
|
Additions
|
|
|
||||||
|
Deductions
|
|
(
|
)
|
|||||
|
Balance, as of December 31, 2023
|
$
|
|
$
|
|
||||
|
Additions
|
|
|
||||||
|
Deductions
|
-
|
(
|
)
|
|||||
|
Balance as of December 31. 2024
|
$
|
|
$
|
|
||||
F - 51
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|